Literature DB >> 27229109

In-depth analysis of clotting dynamics in burn patients.

Shawn Tejiram1, Kathleen E Brummel-Ziedins2, Thomas Orfeo2, Mihriye Mete3, Sameer Desale3, Brittany N Hamilton4, Lauren T Moffatt4, Kenneth G Mann2, Russell P Tracy5, Jeffrey W Shupp6.   

Abstract

BACKGROUND: Studies associating coagulopathic changes with burn injury have relied on limited tests such as partial thromboplastin time (PTT) and international normalized ratio (INR). Understanding the clotting dynamics and associated risk factors after burn injury could influence management. This work aimed to identify real-time changes in coagulation after burn injury not indicated by PTT or INR alone.
MATERIALS AND METHODS: Nine burn-injured patients at a regional burn center were enrolled for blood collection at admission and set intervals over 96 h. Patient demographics, management, and laboratory data (PTT and INR) were collected. Plasma assays determined factors II, V, VII, VIII, IX, X, XI, antithrombin, and protein C functional activity as well as PAP, D-Dimer, fibrin monomer, TFPI, IL-1b, IL-6, IL-10, IL-12p.70, and TNF-α concentrations.
RESULTS: Overall, five patients died. These patients had higher mortality scores and were more acidotic. All patients had normal coagulation studies (INR < 1.5, PTT < 45 s) within 24 h of admission, and only two were abnormal after. Increased factor VIII and IX activity were identified in seven patients at admission. Decreased antithrombin and protein C activity were seen in all patients. Patients had increased PAP, D-Dimer, and fibrin monomer concentrations throughout their hospital course. At admission, increased fold changes were seen in IL-6 (2.5-117) and IL-10 (2.4-32), whereas IL-1b and TNF-α levels were depressed in all patients.
CONCLUSIONS: Extensive changes not identified by PTT or INR were seen after burn injury that may explain perturbed coagulation in these patients. This approach further characterizes the impact thermal injury has on coagulation.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Burn injury; Clotting factor; Coagulopathy; INR; Thermal injury

Mesh:

Substances:

Year:  2016        PMID: 27229109     DOI: 10.1016/j.jss.2016.01.006

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  5 in total

1.  Examining 1:1 vs. 4:1 Packed Red Blood Cell to Fresh Frozen Plasma Ratio Transfusion During Pediatric Burn Excision.

Authors:  Shawn Tejiram; Soman Sen; Kathleen S Romanowski; David G Greenhalgh; Tina L Palmieri
Journal:  J Burn Care Res       Date:  2020-05-02       Impact factor: 1.845

Review 2.  Burn-Induced Coagulopathies: a Comprehensive Review.

Authors:  Robert L Ball; John W Keyloun; Kathleen Brummel-Ziedins; Thomas Orfeo; Tina L Palmieri; Laura S Johnson; Lauren T Moffatt; Anthony E Pusateri; Jeffrey W Shupp
Journal:  Shock       Date:  2020-08       Impact factor: 3.533

3.  Circulating Syndecan-1 and Tissue Factor Pathway Inhibitor, Biomarkers of Endothelial Dysfunction, Predict Mortality in Burn Patients.

Authors:  John W Keyloun; Tuan D Le; Anthony E Pusateri; Robert L Ball; Bonnie C Carney; Thomas Orfeo; Kathleen E Brummel-Ziedins; Maria C Bravo; Melissa M McLawhorn; Lauren T Moffatt; Jeffrey W Shupp
Journal:  Shock       Date:  2021-08-01       Impact factor: 3.533

4.  Assessment of Coagulation Homeostasis in Blunt, Penetrating, and Thermal Trauma: Guidance for a Multicenter Systems Biology Approach.

Authors:  Jeffrey W Shupp; Kathleen E Brummel-Ziedins; Mitchell J Cohen; Kalev Freeman; Rasha Hammamieh; Uma S Mudunuri; Thomas Orfeo; Lauren T Moffatt; Bernard H Brownstein; Kenneth G Mann; Marti Jett; Anthony E Pusateri
Journal:  Shock       Date:  2019-10       Impact factor: 3.454

5.  Heparin resistance in severe thermal injury: A prospective cohort study.

Authors:  Liam D Cato; Benjamin Bailiff; Joshua Price; Christos Ermogeneous; Jon Hazeldine; William Lester; Gillian Lowe; Christopher Wearn; Jonathan R B Bishop; Janet M Lord; Naiem Moiemen; Paul Harrison
Journal:  Burns Trauma       Date:  2021-10-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.